The management of advanced breast cancer has evolved significantly with the introduction of targeted therapies. Palnat (Palbociclib) 75mg, 100mg & 125mg Capsules, manufactured by Cordium Pharmaceuticals Pvt Ltd, provide an evidence-based treatment option for patients diagnosed with Hormone Receptor (HR)-positive and HER2-negative advanced or metastatic breast cancer.

Designed to be used alongside endocrine therapy, Palnat helps slow the growth of cancer cells, enabling oncologists to offer a more personalized and effective treatment strategy.

What Makes Palnat (Palbociclib) Different?

Palnat contains Palbociclib, a selective Cyclin-Dependent Kinase (CDK) 4/6 inhibitor that interrupts cancer cell division. Unlike conventional chemotherapy, Palnat targets specific proteins responsible for tumor growth, making it an important component of modern breast cancer treatment protocols.

The medicine is available in:

• Palnat 75mg Capsules
• Palnat 100mg Capsules
• Palnat 125mg Capsules

These strengths support individualized dosing based on patient tolerance and clinical response.

Therapeutic Uses of Palnat Capsules

Palnat is prescribed for adults with:

✔ HR-Positive Breast Cancer

✔ HER2-Negative Metastatic Breast Cancer

✔ Locally Advanced Breast Cancer

✔ Recurrent Breast Cancer after Hormonal Therapy

✔ Combination Therapy with Aromatase Inhibitors or Fulvestrant

How Does Palnat Work?

Cancer cells rely on CDK4 and CDK6 proteins to multiply rapidly. Palnat blocks these proteins, preventing cancer cells from progressing through the cell cycle.

Clinical Advantages

• Delays cancer progression
• Extends progression-free survival
• Enhances endocrine therapy effectiveness
• Supports personalized oncology treatment
• Helps maintain patients' daily quality of life

Why Oncologists Choose Palnat

Palnat has become an integral part of targeted breast cancer treatment because it offers:

• Scientifically validated CDK4/6 inhibition
• Flexible dosing options
• Consistent pharmaceutical quality
• Better disease management when combined with hormone therapy
• Reduced need for aggressive chemotherapy in appropriate patients

Available Strengths

Treatment decisions should always be made by qualified oncology specialists.

Recommended Administration

Palnat is generally administered:

• Once daily
• For 21 consecutive days
• Followed by a 7-day treatment break
• Repeated every 28-day cycle

Regular blood tests are recommended to monitor treatment response and blood cell counts.

Safety Information

Patients receiving Palnat should undergo routine monitoring throughout therapy.

Possible adverse reactions may include:

• Neutropenia
• Fatigue
• Nausea
• Hair thinning
• Stomatitis
• Mild infections
• Diarrhea
• Reduced appetite

Any unusual symptoms should be reported to the treating physician immediately.

Why Healthcare Providers Trust Cordium Pharmaceuticals Pvt Ltd

Cordium Pharmaceuticals Pvt Ltd is committed to delivering reliable oncology medicines that meet international quality expectations.

Our Strengths

• Premium oncology product portfolio
• WHO-GMP compliant manufacturing practices
• Stringent quality control
• Reliable export documentation
• Secure international packaging
• Timely global supply chain support

Our mission is to improve access to affordable, high-quality cancer medicines for healthcare professionals and patients worldwide.

Global Export Markets

Cordium Pharmaceuticals proudly supports pharmaceutical importers, oncology hospitals, distributors, government tenders, and healthcare organizations across:

🇰🇪 Kenya

🇳🇬 Nigeria

🇬🇭 Ghana

🇵🇭 Philippines

🇻🇳 Vietnam

🇦🇪 United Arab Emirates (UAE)

🇸🇦 Saudi Arabia

🇺🇿 Uzbekistan

🇰🇿 Kazakhstan

🇺🇸 United States (USA)

🇬🇧 United Kingdom (UK)

🇿🇦 South Africa

Why Importers Prefer Cordium Pharmaceuticals

International buyers choose Cordium Pharmaceuticals because we provide:

• Competitive export pricing
• Consistent product availability
• Professional export support
• Oncology-focused manufacturing expertise
• High-quality pharmaceutical packaging
• Long-term supply partnerships

Frequently Asked Questions

What is Palnat used for?

Palnat is prescribed for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with hormone therapy.

Is Palnat available in multiple strengths?

Yes. Palnat is available in 75mg, 100mg, and 125mg Capsules.

Can Palnat replace chemotherapy?

In eligible patients, Palnat combined with endocrine therapy may delay the need for chemotherapy. Treatment decisions should always be made by an oncologist.

Is Palnat suitable for international pharmaceutical procurement?

Yes. Cordium Pharmaceuticals supports global pharmaceutical exports to licensed distributors, hospitals, and importers in multiple countries.

Partner with Cordium Pharmaceuticals Pvt Ltd

If you are a pharmaceutical importer, oncology distributor, hospital procurement team, government healthcare agency, or cancer specialty pharmacy, Cordium Pharmaceuticals Pvt Ltd offers dependable access to Palnat (Palbociclib) 75mg, 100mg & 125mg Capsules with a focus on quality, regulatory compliance, and timely international delivery.

Target Markets: Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.